In glioma grade III, highly activated DEGs included CFAP45, PLBD1, RASSF9, IGKV3-11, IGKV1-5, and NTS, while highly downregulated DEGs included NPAS4 and LINC01007. Here, LINC01007 is linked to central nervous system cancer.